This is a non-core endpoint: only basic statistics are computed.
See its core counterpart C3_OESOPHAGUS_EXALLC for full statistics.
Malignant neoplasm of oesophagus
C3_OESOPHAGUS
esophageal squamous cell carcinoma: Esophageal squamous cell carcinoma (ESCC) is a type of esophageal carcinoma (EC; see this term) that can affect any part of the esophagus, but is usually located in the upper or middle third.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
849 |
4. Check minimum number of eventsNone |
849 |
5. Include endpointsNone |
849 |
6. Filter based on genotype QC (FinnGen only) |
849 |
Control definitions (FinnGen only)
Controls for this endpoint are individuals that are not cases.
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF9
Similar endpoints
↥List of similar endpoints to
Malignant neoplasm of oesophagus
based on the number of shared cases.
Similar with more cases:
- Malignant neoplasm of oesophagus, excluding all cancers (controls excluding all cancers)
- Malignant neoplasm of digestive organs
- Malignant neoplasm of digestive organs, excluding all cancers (controls excluding all cancers)
- Malignant neoplasm
- Malignant neoplasm, excluding all cancers (controls excluding all cancers)
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 849 | 189 | 660 |
| Unadjusted period prevalence (%) | 0.24 | 0.06 | 0.29 |
| Median age at first event (years) | 69.47 | 70.14 | 69.28 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 782
- Matched controls
- 7821
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
C15.5
ICD-10 Finland
Malignant neoplasm: Lower third of oesophagus
1760.5
323.0
536
10
130
Kela drug reimbursment
Malignant tumour
31.5
323.0
506
430
JCF12
NOMESCO Finland
Endoscopic insertion of prosthetic tube into oesphagus
775.5
321.0
295
6
C15.9
ICD-10 Finland
Malignant neoplasm: Oesophagus, unspecified
818.1
293.5
271
5
8070/3-C15.9
ICD-O-3
Squamous cell carcinoma, NOS, of esophagus, NOS
+∞
249.7
226
*
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
15.4
246.9
619
1543
A03FA01
ATC
metoclopramide; systemic, rectal
13.0
216.4
483
864
JCC12
NOMESCO Finland
Thoracoscopic or laparoscopic partial oesophagectomy
664.2
211.6
200
*
C15.4
ICD-10 Finland
Malignant neoplasm: Middle third of oesophagus
+∞
200.9
184
*
JDW98
NOMESCO Finland
Other transluminal endoscopic operation on stomach or duodenum
62.0
178.7
207
45
8140/3-C15.9
ICD-O-3
Adenocarcinoma, NOS, of esophagus, NOS
+∞
156.6
145
*
H02AB02
ATC
dexamethasone; systemic
11.7
151.3
317
431
JC2AB
NOMESCO Finland
Oesophagus X-ray examination with contrast
102.6
145.6
157
19
L01BC06
ATC
capecitabine; oral
24.6
144.1
210
115
A04AA02
ATC
granisetron; systemic, transdermal
15.4
132.6
233
210
R4190
NOMESCO Finland
Nutritional therapy
31.4
127.0
171
69
N02AA05
ATC
oxycodone; systemic
7.1
119.2
364
854
WB113
NOMESCO Finland
Multiple adjuvant cytostatic therapy
22.3
115.8
173
98
WX302
NOMESCO Finland
Thoracal epidural anesthesy
14.8
115.7
205
183
8140/3-C15.5
ICD-O-3
Adenocarcinoma, NOS, of lower third of esophagus
+∞
114.4
107
*
R13
ICD-10 Finland
Dysphagia
12.1
114.4
225
252
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
15.7
112.7
194
161
JN4BD
NOMESCO Finland
Extensive body CT
7.9
109.9
292
548
504
Kela drug reimbursment
Conditions requiring daily forced enteral nutrition
37.3
108.2
139
45
Z51.5
ICD-10 Finland
Palliative care
9.9
107.1
237
328
JD1EE
NOMESCO Finland
Ultrasound examination of gastro-oesophageal reflux
302.5
105.6
105
*
C15.3
ICD-10 Finland
Malignant neoplasm: Upper third of oesophagus
+∞
104.6
98
*
C15.1
ICD-10 Finland
Malignant neoplasm: Thoracic part of oesophagus
1051.7
97.2
93
*
WX600
NOMESCO Finland
Single shot through catheter
52.6
94.6
113
25
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
10.5
94.2
198
244
WB121
NOMESCO Finland
Demanding neoadjuvant cytostatic therapy
43.0
86.9
108
29
JCA55
NOMESCO Finland
Endoscopic dilatation of oesophagus
47.8
85.5
104
25
UJC12
NOMESCO Finland
Flexible oesophagoscopy
55.0
85.3
101
21
JCC10
NOMESCO Finland
Transthoracic partial oesophagectomy without interposition
309.7
83.3
83
*
C15.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of oesophagus
+∞
81.7
77
*
C15.0
ICD-10 Finland
Malignant neoplasm: Cervical part of oesophagus
850.6
79.9
77
*
D37.7
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Other digestive organs
18.0
77.0
123
80
A04AA01
ATC
ondansetron; systemic, rectal
9.5
75.3
166
216
N02AB03
ATC
fentanyl; nasal, sublingual, transdermal
9.5
74.5
164
213
K22.2
ICD-10 Finland
Oesophageal obstruction
29.6
73.0
99
38
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
11.0
62.7
125
133
WX602
NOMESCO Finland
Repeated or continuing anesthesia shots throug a catheter
7.6
59.7
151
240
WF004
NOMESCO Finland
Palliative radiotherapy
14.2
51.6
90
71
JDB10
NOMESCO Finland
Percutaneous gastrostomy
18.8
51.5
80
47
8070/3-C15.5
ICD-O-3
Squamous cell carcinoma, NOS, of lower third of esophagus
+∞
50.6
48
*
WF002
NOMESCO Finland
Radical radiotherapy
6.4
47.3
134
245
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
3.6
46.8
262
958
WF001
NOMESCO Finland
Preoperative radiotherapy
29.7
46.8
63
23
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
3.1
44.2
347
1613
JN5DR
NOMESCO Finland
PET-CT of upper body metabolism
19.0
44.1
68
39
A02BC02
ATC
pantoprazole; systemic
3.1
43.4
597
3981
YG1BD
NOMESCO Finland
Extensive CT examination of thorax for dose design of radiotherapy
11.0
40.4
79
79
XJD02
NOMESCO Finland
Peroral endoscopic ultrasonography
27.5
39.4
54
21
A04AA55
ATC
palonosetron, combinations; systemic
14.2
39.4
68
52
D77
ICPC
Malignant digestive neopl other/NOS
40.1
39.2
49
13
WX404
NOMESCO Finland
Intravenous generell anesthesy
3.4
38.4
226
838
WF049
NOMESCO Finland
Radiotherapy of metastasis
8.1
38.1
89
122
8070/3-C15.4
ICD-O-3
Squamous cell carcinoma, NOS, of middle third of esophagus
+∞
34.6
33
*
XX3DW
NOMESCO Finland
Time consuming IT work
3.8
34.3
161
494
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
5.6
34.1
105
210
K22.1
ICD-10 Finland
Ulcer of oesophagus
10.7
34.0
67
68
C15.2
ICD-10 Finland
Malignant neoplasm: Abdominal part of oesophagus
+∞
33.6
32
*
YG1CD
NOMESCO Finland
Very extensive CT examination of thorax for dose design of radiotherapy
58.5
33.5
39
7
601
Kela drug reimbursment
Severe malabsorption of nutrients, mainly fats
19.7
33.1
50
27
UGC12
NOMESCO Finland
Flexible bronchoscopy
4.0
33.0
145
419
JDA55
NOMESCO Finland
Endoscopic dilatation of stomach, pylorus or anastomosis of stomach
56.9
32.5
38
7
JN3AA
NOMESCO Finland
Abdominal X-ray examination without contrast
5.7
31.8
97
191
UJD02
NOMESCO Finland
Gastroscopy
5.4
31.6
101
210
WW500
NOMESCO Finland
Blood transfusion
6.4
31.5
87
151
JN4AD
NOMESCO Finland
Body CT examination
4.1
31.4
133
370
WX402
NOMESCO Finland
General anaesthesia
3.4
30.9
173
607
YG1AD
NOMESCO Finland
CT examination of thorax for dose design of radiotherapy
17.8
30.1
47
28
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
5.5
29.5
92
186
ZX120
NOMESCO Finland
Intravenous
3.8
29.5
135
402
WZC30
NOMESCO Finland
Teaching
3.2
29.1
174
638
A04AD12
ATC
aprepitant; systemic
11.1
28.2
54
52
ZX095
NOMESCO Finland
Combined chemoradiotherapy
18.1
27.8
43
25
C16.00
ICD-10 Finland
Cardia
31.4
27.4
36
12
GD5BD
NOMESCO Finland
Thorax and upper abdomen combined extensive CT examination of
8.4
27.2
61
78
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
5.7
26.6
79
150
J38.0
ICD-10 Finland
Paralysis of vocal cords and larynx
10.6
26.1
51
51
TPX10
NOMESCO Finland
Implantation of vascular injection port
7.1
25.6
64
97
D13.0
ICD-10 Finland
Benign neoplasm: Oesophagus
51.9
25.4
30
6
JN4CD
NOMESCO Finland
Very extensive body CT
5.2
25.4
82
172
RD210
NOMESCO Finland
NA
14.7
25.1
42
30
TJD20
NOMESCO Finland
Change of gastrostomy tube
38.9
24.1
30
8
B01AB05
ATC
enoxaparin; parenteral
2.3
23.8
300
1668
JCA45
NOMESCO Finland
Endoscopic mucosal or submucosal resection in oesophagus
247.2
23.8
24
*
1CD01
NOMESCO Finland
NA
55.8
23.2
27
5
JCA08
NOMESCO Finland
Endoscopic removal of foreign body from oesophagus
55.8
23.2
27
5
JDB00
NOMESCO Finland
Gastrostomy
67.1
23.0
26
*
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
3.3
22.5
124
422
WX408
NOMESCO Finland
General anesthesy, balanced
2.3
22.5
260
1379
D84
ICPC
Oesophagus disease
46.5
22.5
27
6
K22.7
ICD-10 Finland
Barrett oesophagus
12.0
22.4
41
36
Z71.3
ICD-10 Finland
Dietary counselling and surveillance
5.2
22.0
70
144
8000/3-C15.9
ICD-O-3
Neoplasm, malignant of esophagus, NOS
+∞
22.0
21
*
A98
ICPC
Health maint/preventive medicine
0.5
21.8
485
6119
JFF00
NOMESCO Finland
Catheter enterostomy
118.3
21.7
23
*
ZX090
NOMESCO Finland
Other technic of radiotherapy
6.7
21.3
55
87
WD115
NOMESCO Finland
Multiple cystostatic therapy of methastized malignancy
9.4
21.3
44
49
WX872
NOMESCO Finland
Intensive care
3.9
21.2
92
259
8140/3-C15.2
ICD-O-3
Adenocarcinoma, NOS, of abdominal esophagus
+∞
20.9
20
*
R4110
NOMESCO Finland
Physiotherapy
2.3
20.8
249
1332
8140/3-C16.0
ICD-O-3
Adenocarcinoma, NOS, of cardia, NOS
26.3
20.5
28
11
WX000
NOMESCO Finland
Monitoring vital functions without anesthesy
5.6
20.4
61
117
GD1AA
NOMESCO Finland
Thorax X-ray examination
2.0
20.3
413
2772
A02BC05
ATC
esomeprazole; systemic
2.1
19.6
340
2130
WX002
NOMESCO Finland
Sedation and analgesia
2.3
18.7
198
990
C78.0
ICD-10 Finland
Secondary malignant neoplasm of lung
6.8
18.2
46
71
K22.9
ICD-10 Finland
Disease of oesophagus, unspecified
23.4
17.8
25
11
C15
ICD-10 Finland
Malignant neoplasm of oesophagus
+∞
17.8
17
*
GD1BD
NOMESCO Finland
Thorax extensive CT-examination
3.7
17.6
81
239
GAA10
NOMESCO Finland
Intercostal insertion of pleural drainage tube
6.4
17.5
46
75
WB123
NOMESCO Finland
Demanding adjuvant cytostatic therapy
14.3
17.4
29
21
TPH30
NOMESCO Finland
Insertion of central venous catheter through periferal vein
9.1
16.8
35
40
GA4AT
NOMESCO Finland
Cathetrisation of pleural cavity with ultrasound guidance
10.7
16.8
32
31
TJF00
NOMESCO Finland
Insertion of jejunal tube
64.8
16.8
19
*
ZX070
NOMESCO Finland
Intensity modified radiotherapy
5.9
16.7
47
84
RD160
NOMESCO Finland
NA
92.0
16.6
18
*
K92.0
ICD-10 Finland
Haematemesis
5.5
16.6
49
93
C16.09
ICD-10 Finland
Malignant tumor of cardiac or other unspecified carcinoma
20.6
16.5
24
12
1505A
ICD-9 Finland
Malignant neoplasm of oesophagus, Lower third of oesophagus
+∞
15.7
15
*
T18.1
ICD-10 Finland
Foreign body in oesophagus
12.1
15.6
28
24
C78.7
ICD-10 Finland
Secondary malignant neoplasm of liver and intrahepatic bile duct
5.7
15.6
45
83
WB103
NOMESCO Finland
Simple adjuvant cytostatic therapy
5.8
15.6
44
79
A06AH03
ATC
naloxegol; oral
7.5
15.4
36
50
WVC10
NOMESCO Finland
Subcutaneous infusion of drugs
23.9
15.2
21
9
TPH04
NOMESCO Finland
Cathetrisation of vein
2.1
15.1
200
1097
JCA98
NOMESCO Finland
Other local endoscopic operation on oesophagus
32.4
14.9
19
6
L03
ICPC
Low back symptom/complaint
0.3
14.5
34
1021
IAZ97
NOMESCO Finland
Psychiatric consultation in another specialty
15.7
14.5
23
15
L03AA13
ATC
pegfilgrastim; parenteral
4.9
14.0
46
99
PJD53
NOMESCO Finland
Block dissection of aortic lymph nodes
76.5
13.6
15
*
JCC30
NOMESCO Finland
Transthoracic partial oesophagectomy with interposition of intestine
+∞
13.6
13
*
8070/3-C15.3
ICD-O-3
Squamous cell carcinoma, NOS, of upper third of esophagus
+∞
13.6
13
*
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
4.6
13.4
46
104
R11
ICD-10 Finland
Nausea and vomiting
3.1
13.3
75
258
JN4JR
NOMESCO Finland
Whole body extensive metabolic PET with CT
14.1
13.3
22
16
OAB73
NOMESCO Finland
Prevention and treatment of malnutrition
11.8
12.9
23
20
A49.9
ICD-10 Finland
Bacterial infection, unspecified
2.3
12.8
130
629
L03AA02
ATC
filgrastim; parenteral
4.7
12.7
43
96
JCC00
NOMESCO Finland
Transhiatal partial oesophagectomy without interposition
+∞
12.5
12
*
8144/3-C15.9
ICD-O-3
Adenocarcinoma, intestinal type of esophagus, NOS
+∞
12.5
12
*
JCF00
NOMESCO Finland
Insertion of prosthetic tube into oesphagus
+∞
12.5
12
*
JC2KB
NOMESCO Finland
Functional X-ray examination of swallowing
8.9
12.1
25
29
A79
ICPC
Malignancy NOS
7.0
12.0
29
43
K22.3
ICD-10 Finland
Perforation of oesophagus
47.4
11.9
14
*
JCB00
NOMESCO Finland
Oesophagostomy
+∞
11.5
11
*
D00.1
ICD-10 Finland
Carcinoma in situ: Oesophagus
121.7
11.5
12
*
JFF01
NOMESCO Finland
Laparoscopic catheter enterostomy
121.7
11.5
12
*
JAH00
NOMESCO Finland
Laparotomy
4.5
11.2
39
90
C77.8
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Lymph nodes of multiple regions
12.9
11.2
19
15
WB111
NOMESCO Finland
Multiple neoadjuvant cytostatic therapy
43.9
10.9
13
*
JCA52
NOMESCO Finland
Other endoscopic procedure using diathermy or heat in oesophagus
60.8
10.6
12
*
Z43.1
ICD-10 Finland
Attention to gastrostomy
60.8
10.6
12
*
R52.0
ICD-10 Finland
Acute pain
5.0
10.6
33
68
GBA35
NOMESCO Finland
Endoscopic insertion of stent into trachea
111.4
10.4
11
*
8010/3-C15.9
ICD-O-3
Carcinoma, NOS, of esophagus, NOS
+∞
10.4
10
*
8144/3-C15.5
ICD-O-3
Adenocarcinoma, intestinal type of lower third of esophagus
+∞
10.4
10
*
YA1BD
NOMESCO Finland
Extensive CT examination of head and neck for dose design of radiotherapy
9.7
10.3
20
21
J01MA12
ATC
levofloxacin; systemic
1.8
10.2
185
1124
Z98.8
ICD-10 Finland
Other specified postsurgical states
7.4
10.0
23
32
GBB00
NOMESCO Finland
Tracheostomy
6.3
9.7
25
41
SPAT1223
SPAT
Implementation of physical therapy rehabilitation plan
0.5
9.5
81
1487
WC125
NOMESCO Finland
Demanding cytostatic therapy of local tumor recidive
30.4
9.4
12
*
C77.2
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Intra-abdominal lymph nodes
12.5
9.4
16
13
GA4YT
NOMESCO Finland
Puncture of pleura with ultrasound guidance
3.4
9.4
44
134
YX9BD
NOMESCO Finland
Other extensive CT eamination for dose design of radiotherapy
8.8
9.3
19
22
C10AA07
ATC
rosuvastatin; oral
0.5
9.3
71
1348
JAH01
NOMESCO Finland
Laparoscopy
4.1
9.2
35
89
K21.0
ICD-10 Finland
Gastro-oesophageal reflux disease with oesophagitis
2.2
9.1
94
455
GD1AD
NOMESCO Finland
Thorax CT examination
3.0
9.1
52
182
L01BC53
ATC
tegafur, combinations; systemic
37.1
9.0
11
*
A06AD11
ATC
lactulose; oral
1.9
8.9
151
889
UGB02
NOMESCO Finland
Tracheoscopy
24.3
8.9
12
5
D21
ICPC
Swallowing problem
5.7
8.8
24
43
N03AX16
ATC
pregabalin; oral
1.8
8.8
178
1111
C79.30
ICD-10 Finland
Secondary malignant tumor of the cerebrum
7.3
8.8
20
28
TPH90
NOMESCO Finland
Removal of fixed intravenous catheter
6.7
8.7
21
32
N05BA06
ATC
lorazepam; systemic, sublingual
2.7
8.7
58
224
J18.9
ICD-10 Finland
Pneumonia, unspecified
1.7
8.6
239
1639
YX9AD
NOMESCO Finland
Other CT eamination for dose design of radiotherapy
4.0
8.6
33
85
GAB10
NOMESCO Finland
Antero- or postero-lateral thoracotomy
9.6
8.3
16
17
SPAT1033
SPAT
Irrigation or wax removal of outer auditory canal
0.5
8.2
62
1184
FN1AC
NOMESCO Finland
Angiography of heart and/or coronary arteries
0.5
8.1
93
1567
178
Kela drug reimbursment
Combination product containing tegafur, gimeracil and oteracil
33.7
8.1
10
*
R4130
NOMESCO Finland
Speech therapy
4.3
7.8
27
64
N02AA03
ATC
hydromorphone; systemic, rectal
15.2
7.7
12
8
SPAT1109
SPAT
Analgesia with portable analgesic pump
8.1
7.6
16
20
C16.04
ICD-10 Finland
Malignant tumor of cardiac intestinal carcinoma
18.6
7.6
11
6
C16.03
ICD-10 Finland
Malignant tumor of cardiac diffuse carcinoma
25.3
7.6
10
*
B01AB10
ATC
tinzaparin; parenteral
2.4
7.5
64
285
8144/3-C16.0
ICD-O-3
Adenocarcinoma, intestinal type of cardia, NOS
80.8
7.4
8
*
WD405
NOMESCO Finland
Simple antiboidy therapy of methastized malignancy
4.1
7.3
27
68
1504A
ICD-9 Finland
Malignant neoplasm of oesophagus, Middle third of oesophagus
+∞
7.3
7
*
GCA32
NOMESCO Finland
Endoscopic insertion of stent into bronch
+∞
7.3
7
*
L15
ICPC
Knee symptom/complaint
0.4
7.3
42
879
J69.0
ICD-10 Finland
Pneumonitis due to food and vomit
3.6
7.3
31
89
C77.1
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Intrathoracic lymph nodes
15.9
7.2
11
7
T05
ICPC
Feeding problem of adult
7.4
7.2
16
22
R63.8
ICD-10 Finland
Other symptoms and signs concerning food and fluid intake
20.2
7.1
10
5
K20
ICD-10 Finland
Oesophagitis
4.6
7.1
23
51
JN4KR
NOMESCO Finland
Whole body very extensive metabolic PET with CT
8.9
7.1
14
16
C78.6
ICD-10 Finland
Secondary malignant neoplasm of retroperitoneum and peritoneum
7.1
7.0
16
23
M25.5
ICD-10 Finland
Pain in joint
0.5
6.9
61
1113
N40
ICD-10 Finland
Hyperplasia of prostate
0.6
6.8
133
1975
I50.0
ICD-10 Finland
Congestive heart failure
0.3
6.7
18
513
E78.0
ICD-10 Finland
Pure hypercholesterolaemia
0.5
6.6
51
976
C10AA05
ATC
atorvastatin; oral
0.6
6.6
187
2561
JF1AB
NOMESCO Finland
Passage examination of small bowell with X-ray
4.9
6.6
20
42
I50.1
ICD-10 Finland
Left ventricular failure
0.2
6.5
6
303
L17
ICPC
Foot/toe symptom/complaint
0.5
6.5
68
1185
N02AA01
ATC
morphine; systemic, rectal
3.9
6.5
25
66
J86.9
ICD-10 Finland
Pyothorax without fistula
5.8
6.5
17
30
JX1XB
NOMESCO Finland
Other X-ray examination of alimentary tract with contrast
70.4
6.4
7
*
C79.5
ICD-10 Finland
Secondary malignant neoplasm of bone and bone marrow
3.5
6.3
27
79
8070/3-C15.0
ICD-O-3
Squamous cell carcinoma, NOS, of cervical esophagus
+∞
6.3
6
*
8480/3-C15.5
ICD-O-3
Mucinous adenocarcinoma of lower third of esophagus
+∞
6.3
6
*
8246/3-C15.9
ICD-O-3
Neuroendocrine carcinoma, NOS, of esophagus, NOS
+∞
6.3
6
*
6312
FHL
Gastrostomy
+∞
6.3
6
*
JCC96
NOMESCO Finland
Other partial oesophagectomy
26.9
6.2
8
*
EB1SA
NOMESCO Finland
Dental X-ray, bite-wing X-ray on one side of the mouth
0.6
6.2
110
1670
GD1CD
NOMESCO Finland
Thorax extensive CT-examination
5.8
6.2
16
28
QBB10
NOMESCO Finland
Major dressing of wound of skin of trunk
3.2
6.1
30
97
AAG50
NOMESCO Finland
Stereotactic intracranial radiotherapy
12.6
6.1
10
8
AA1BD
NOMESCO Finland
Extensive CT of head and brain
3.2
6.1
29
92
XKD00
NOMESCO Finland
Uroflowmetry
0.6
6.1
77
1275
S01XA20
ATC
artificial tears and other indifferent preparations; ophthalmic
0.6
6.0
141
2018
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
411
834
8.61
216.85
4.8
4.3
37.1
20.9
ug/l
0.46
375
711
199
313
8.00
126.85
4.0
3.7
1086.4
12806.6
u/ml
0.70
189
259
146
169
10.23
119.36
4.4
3.5
597.2
350.5
u/ml
0.26
133
159
377
1212
4.80
108.74
5.4
3.6
0.8
0.8
mmol/l
11.10
370
1138
241
742
4.14
69.59
2.9
2.2
0.2
0.2
g/l
2.82
231
681
290
1021
3.80
68.98
5.1
6.4
0.9
1.0
mmol/l
8.18
281
950
546
3101
3.13
55.41
9.6
5.2
31.1
34.7
g/l
32.65
535
2876
346
1714
2.72
42.21
3.9
2.6
—
—
—
0
0
199
734
3.24
41.67
3.7
8.2
6.7
11.0
mmol/l
17.26
189
697
430
6114
0.40
37.48
5.5
6.5
40.5
41.1
mmol/mol
0.73
378
5581
561
3642
2.59
37.39
14.1
6.8
10.5
12.8
umol/l
5.44
554
3462
473
6408
0.41
34.73
3.9
5.4
2.5
2.6
mmol/l
0.24
412
5766
459
6257
0.42
32.96
3.5
4.8
4.4
4.4
mmol/l
0.13
410
5687
453
6196
0.42
32.44
3.5
4.8
1.4
1.4
mmol/l
0.42
398
5578
396
2334
2.31
30.68
6.4
3.5
2.3
2.3
mmol/l
0.24
366
2000
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
102
299
3.74
30.13
2.5
2.6
0.3
0.3
u/ml
2.15
58
170
536
3722
2.19
26.11
15.3
9.2
4.2
4.3
e9/l
0.13
499
3242
478
3211
2.12
24.91
6.1
4.3
—
—
—
0
0
460
6002
0.49
22.37
3.4
4.3
1.3
1.3
mmol/l
0.16
408
5380
251
1376
2.17
21.67
7.0
3.3
2.5
2.5
mmol/l
10.60
230
1197
126
554
2.50
17.95
1.6
1.7
—
—
—
0
0
214
1207
2.03
16.54
1.7
2.1
30.0
30.0
s
0.02
209
1168
284
4105
0.54
15.83
3.8
5.2
2.3
3.1
ug/l
1.44
242
3638
316
2066
1.84
15.52
4.0
3.4
32.9
34.5
u/l
0.45
309
1956
208
3292
0.51
15.46
3.7
4.5
21.8
21.3
%
0.21
96
1694
324
2178
1.79
14.23
2.8
2.6
53.7
57.6
u/l
0.89
312
2019
542
4256
1.76
13.48
9.6
5.2
6.7
6.9
mmol/l
2.33
532
4020
451
5611
0.58
13.23
3.8
4.3
2.0
2.0
mu/l
0.07
395
4973
331
4419
0.59
12.29
3.4
3.5
15.2
15.1
pmol/l
0.24
296
3885
461
3533
1.67
11.86
10.7
7.4
1.2
1.2
mmol/l
0.85
390
2953
82
362
2.40
11.46
2.3
2.0
0.9
2.3
ug/l
0.95
74
322
92
1770
0.46
11.33
1.6
1.7
1.2
1.4
mmol/l
1.24
79
1431
165
963
1.89
11.11
14.4
7.6
1.6
1.0
mmol/l
0.95
149
738
130
705
2.00
10.86
13.1
7.5
1.3
1.4
mmol/l
1.45
125
676
95
463
2.18
10.53
1.7
1.5
—
—
—
0
0
147
2374
0.54
10.45
2.7
3.2
0.7
0.8
ug/l
0.93
102
1655
424
3259
1.60
10.19
10.0
6.5
1.2
1.2
mmol/l
3.03
400
2943
539
6272
0.61
9.97
4.3
5.0
6.1
6.1
mmol/l
0.60
498
5594
101
529
2.03
9.26
17.4
9.6
0.7
0.7
%
0.50
101
524
158
2432
0.57
9.21
3.5
4.0
10.8
9.6
mg/mmol
0.11
104
1610
101
536
2.00
8.92
17.4
9.4
1.3
1.4
%
0.07
101
531
604
5180
1.58
8.07
14.9
8.1
95.0
80.2
u/l
6.72
589
4845
156
2318
0.60
7.62
2.5
3.2
7.5
7.8
mmol/l
0.32
125
1913
130
791
1.76
7.48
2.6
2.9
10.5
10.4
umol/l
0.01
119
706
630
6954
0.64
7.25
48.5
25.5
118.1
135.7
g/l
108.99
619
6807
630
6953
0.64
7.23
48.1
25.4
4.0
4.5
e12/l
70.75
612
6705
40
905
0.41
7.22
1.1
1.3
66.4
45.8
iu/ml
0.47
13
271
630
6951
0.64
7.18
48.2
25.4
263.5
234.7
e9/l
14.67
614
6734
109
639
1.81
7.11
2.1
2.5
32.1
40.8
u/l
0.60
93
550
38
857
0.42
6.80
1.1
1.2
2.3
12.7
u/ml
3.27
15
300
245
3152
0.69
5.66
3.1
3.8
0.0
0.0
estimate
0.00
55
583
182
1300
1.51
5.39
1.7
2.0
—
—
—
0
0
245
3129
0.69
5.35
3.1
3.8
0.0
0.0
estimate
0.00
53
612
169
1191
1.52
5.33
2.0
2.7
9.5
12.6
umol/l
5.56
163
1099
244
3109
0.70
5.22
4.3
5.1
0.0
0.0
estimate
0.00
54
621
618
6737
0.70
4.99
18.0
11.5
24.1
26.8
u/l
3.28
601
6457
12
403
0.29
4.98
2.3
2.5
—
11.6
—
0
13
237
3016
0.70
4.96
2.3
2.3
—
—
—
0
0
625
6789
0.70
4.80
40.9
20.9
3.9
4.0
mmol/l
14.34
615
6591
36
164
2.25
4.78
1.2
1.4
—
—
—
0
0
36
164
2.25
4.78
1.2
1.4
—
—
—
0
0
155
1104
1.49
4.61
1.8
2.7
2.3
2.2
g/l
0.41
146
1023
625
6772
0.71
4.51
40.6
20.7
138.1
139.6
mmol/l
30.67
616
6581
415
4783
0.74
4.45
2.9
4.1
18.4
13.8
mm/h
5.08
368
4353
549
6064
0.73
4.37
34.8
16.2
86.5
74.9
ml/min/173m2
36.40
509
5089
35
689
0.49
4.35
2.1
2.2
10.4
12.9
nmol/l
1.20
27
600
142
1944
0.68
4.33
2.4
3.0
4410.9
7874.2
umol/l
0.38
118
1658
167
2204
0.70
4.15
1.8
2.3
216.5
270.4
u/l
0.58
159
2063
56
317
1.82
4.14
7.6
3.9
1.2
1.4
mmol/l
1.35
56
311
33
157
2.15
3.99
1.1
1.3
—
—
—
0
0
12
356
0.33
3.98
1.2
1.4
—
53.8
—
0
21
11
341
0.31
3.97
1.6
1.8
—
—
—
0
0
146
1058
1.46
3.97
1.9
2.7
17.0
22.6
%
4.60
127
897
86
556
1.61
3.95
5.2
2.9
73.3
60.9
ml/min/173m2
1.80
31
227
238
1884
1.37
3.89
2.1
2.2
3.8
3.1
mg/l
2.10
205
1582
129
917
1.48
3.86
1.8
1.9
—
—
—
0
0
187
1433
1.39
3.72
3.3
4.1
191.4
399.8
ng/l
0.98
162
1230
12
35
3.46
3.63
1.8
3.5
23.2
64.2
u/ml
0.77
12
35
24
105
2.32
3.55
1.4
1.4
77526.9
22020.5
e6/l
0.33
16
64
26
119
2.22
3.47
1.4
1.4
1071.2
1581.5
e6/l
0.60
20
84
193
2421
0.74
3.40
3.2
4.1
—
—
—
0
0
126
918
1.44
3.32
1.7
1.8
—
—
—
0
0
12
38
3.19
3.22
1.8
2.4
—
—
—
0
0
74
1089
0.65
3.18
1.2
1.2
4.9
1.4
u/ml
0.54
17
282
19
79
2.44
3.15
3.1
3.0
7.8
5.6
nmol/l
0.18
19
79
7
216
0.32
3.08
1.1
1.3
—
—
—
0
0
252
2073
1.31
3.08
2.9
3.4
1.1
0.6
e6/l
0.39
207
1602
101
732
1.43
2.76
3.2
3.8
3.4
1.9
mmol/l
2.09
78
575
11
37
3.00
2.70
3.1
3.9
115.2
82.0
nmol/l
0.24
11
37
34
191
1.81
2.66
1.6
2.2
78.4
85.0
%
0.72
34
181
62
895
0.67
2.44
3.6
4.8
30.4
31.9
%
0.70
42
592
26
138
1.91
2.43
2.7
3.2
65.2
58.2
%
1.62
26
138
8
202
0.39
2.31
1.8
1.8
41.1
42.4
nmol/l
—
8
192
151
1203
1.31
2.29
2.6
3.2
2.2
1.3
e6/l
0.82
94
724
16
72
2.25
2.28
1.9
1.5
—
—
—
0
0
100
750
1.38
2.27
1.8
2.7
4.0
7.6
ug/l
3.60
85
672
91
673
1.39
2.24
2.1
3.0
59.1
65.8
g/l
6.90
85
612
195
1613
1.27
2.22
2.3
2.7
7.0
4.0
e6/l
1.38
182
1412
208
2458
0.80
2.16
2.2
2.2
72.6
77.4
nmol/l
1.71
189
2141
138
1099
1.31
2.11
17.2
27.9
1.3
1.4
inr
0.29
24
149
8
193
0.41
2.06
1.1
1.3
—
—
—
0
0
29
172
1.71
1.95
1.7
2.4
247.8
207.3
%
1.36
29
161
8
185
0.43
1.95
1.3
1.3
1.3
1.2
g/l
—
8
177
0
53
0.00
1.87
0.0
1.5
—
275.0
—
0
6
47
319
1.50
1.85
1.7
2.0
—
—
—
0
0
10
40
2.52
1.84
2.6
1.9
—
—
—
0
0
37
239
1.57
1.82
1.3
1.3
—
—
—
0
0
12
53
2.28
1.81
1.2
1.2
—
—
—
0
0
12
243
0.49
1.74
1.5
1.6
—
140.0
—
0
11
23
133
1.75
1.71
2.5
2.8
5.4
4.6
e9/l
0.62
23
133
8
179
0.44
1.70
1.3
1.3
0.2
0.2
g/l
—
8
169
36
235
1.56
1.70
1.6
1.7
—
—
—
0
0
0
49
0.00
1.68
0.0
1.4
—
55.0
—
0
8
42
285
1.50
1.67
1.5
1.8
—
—
—
0
0
14
69
2.05
1.65
1.1
1.3
—
—
—
0
0
214
2460
0.83
1.64
2.5
3.2
1396.1
1805.1
ng/l
1.45
189
2148
114
1396
0.79
1.59
2.8
4.2
1.0
1.0
kg/l
0.13
15
221
149
1767
0.81
1.56
3.0
4.1
0.0
0.0
estimate
0.50
47
578
14
71
1.99
1.54
1.2
1.9
—
—
—
0
0
0
44
0.00
1.51
0.0
1.1
—
—
—
0
0
0
44
0.00
1.51
0.0
1.1
—
—
—
0
0
0
45
0.00
1.50
0.0
1.1
—
—
—
0
0
0
45
0.00
1.50
0.0
1.1
—
—
—
0
0
0
45
0.00
1.50
0.0
1.1
—
—
—
0
0
20
116
1.74
1.49
1.4
1.6
—
—
—
0
0
5
16
3.14
1.44
1.0
1.3
—
—
—
0
0
79
617
1.31
1.43
6.1
4.5
1.2
1.2
mmol/l
0.24
74
538
5
123
0.40
1.37
1.0
1.1
—
—
—
0
0
20
120
1.68
1.35
1.3
1.7
—
—
—
0
0
7
150
0.46
1.32
1.6
1.9
163.0
217.5
pmol/l
—
7
138
21
129
1.64
1.31
1.4
1.5
—
—
—
0
0
6
132
0.45
1.29
1.2
1.1
—
—
—
0
0
6
134
0.44
1.28
3.0
1.6
—
—
—
0
0
23
147
1.58
1.24
1.4
1.6
—
—
—
0
0
20
312
0.63
1.22
1.4
1.4
—
—
—
0
0
478
5067
0.87
1.22
43.7
21.2
15.1
13.9
%
28.70
468
4954
20
124
1.63
1.21
1.5
1.6
—
—
—
0
0
29
197
1.49
1.20
1.3
1.6
282.8
256.1
ug/g
0.39
22
120
23
149
1.56
1.18
1.3
2.0
—
—
—
0
0
16
95
1.70
1.14
1.4
1.9
—
—
—
0
0
9
163
0.55
1.09
1.0
1.2
435.7
531.4
mg/l
—
9
151
5
21
2.39
1.09
1.2
1.3
—
—
—
0
0
13
74
1.77
1.07
1.1
1.1
—
—
—
0
0
6
123
0.48
1.05
1.2
1.3
—
—
—
0
0
146
1269
1.18
1.04
2.5
3.0
2.1
1.0
e6/l
1.49
87
782
21
311
0.67
1.04
1.4
2.7
—
—
—
0
0
21
311
0.67
1.04
1.4
2.7
4.1
3.8
g/l
0.64
16
218
21
311
0.67
1.04
1.4
2.7
7.2
7.3
g/l
0.20
16
226
9
46
1.97
1.03
1.7
1.8
—
—
—
0
0
9
46
1.97
1.03
1.7
1.8
—
—
—
0
0
0
30
0.00
0.97
0.0
1.0
—
—
—
0
0
14
223
0.62
0.97
1.0
1.0
—
—
—
0
0
0
31
0.00
0.96
0.0
1.1
—
—
—
0
0
28
200
1.41
0.94
1.5
1.5
—
—
—
0
0
11
184
0.59
0.93
1.8
1.7
10045.8
16044.3
e6/l
—
6
140
8
146
0.54
0.93
1.6
1.6
—
—
—
0
0
74
890
0.82
0.92
13.1
8.4
—
—
—
0
0
12
195
0.61
0.91
1.5
1.6
0.1
0.1
iu/ml
—
5
39
13
207
0.62
0.91
1.6
1.4
—
—
—
0
0
62
505
1.25
0.87
1.8
1.7
—
—
—
0
0
6
31
1.94
0.84
1.0
1.1
—
—
—
0
0
8
137
0.58
0.84
1.0
1.2
3.5
3.9
mmol/l
—
8
126
27
197
1.38
0.83
1.3
1.8
—
—
—
0
0
8
46
1.75
0.82
1.1
1.4
—
—
—
0
0
47
586
0.79
0.82
1.3
1.3
—
—
—
0
0
9
147
0.61
0.79
1.4
1.3
—
—
—
0
0
373
3949
0.90
0.79
3.2
3.4
91.1
61.3
u/l
2.46
352
3629
292
2715
1.12
0.79
2.9
3.4
—
—
—
0
0
0
25
0.00
0.79
0.0
1.2
—
—
—
0
0
0
26
0.00
0.78
0.0
1.0
—
—
—
0
0
167
1503
1.14
0.78
2.0
1.8
1187.5
1178.0
nmol/l
0.04
133
1135
5
24
2.09
0.74
4.2
2.1
—
—
—
0
0
108
946
1.16
0.74
2.8
4.3
236.9
247.2
u/l
0.35
102
890
27
202
1.35
0.73
1.3
1.8
—
—
—
0
0
6
108
0.55
0.72
1.0
1.4
—
140.4
—
0
19
11
68
1.63
0.72
1.1
1.2
120.6
108.0
%
0.53
11
62
9
58
1.56
0.70
1.7
1.7
—
—
—
0
0
41
330
1.25
0.67
2.2
2.9
—
—
—
0
0
11
71
1.56
0.62
1.5
1.7
—
—
—
0
0
0
20
0.00
0.60
0.0
1.1
—
—
—
0
0
0
21
0.00
0.60
0.0
1.0
—
—
—
0
0
0
21
0.00
0.60
0.0
1.1
—
—
—
0
0
0
21
0.00
0.60
0.0
1.1
—
—
—
0
0
0
22
0.00
0.59
0.0
1.5
—
—
—
0
0
622
6370
0.91
0.56
36.1
17.6
44.4
28.4
mg/l
20.70
600
5212
17
226
0.75
0.52
1.2
1.5
—
—
—
0
0
146
1585
0.90
0.50
1.7
1.8
417.8
23507020.2
pmol/l
1.21
122
1289
6
41
1.47
0.50
4.3
4.0
—
—
—
0
0
12
84
1.43
0.49
6.0
3.9
—
—
—
0
0
10
143
0.70
0.48
1.0
1.3
—
456.7
—
0
6
48
557
0.85
0.47
3.1
3.7
5.3
5.1
kpa
0.74
43
514
45
523
0.85
0.45
2.8
3.8
3.2
1.8
mmol/l
1.10
37
394
7
50
1.40
0.45
1.4
3.1
—
—
—
0
0
148
1371
1.10
0.45
1.6
1.7
2.3
1.4
mg/l
1.69
123
1081
267
2536
1.08
0.45
2.6
2.9
183.1
182.4
ug/l
0.01
242
2282
11
78
1.42
0.43
1.2
1.2
2.0
6.3
u/ml
—
5
33
16
122
1.32
0.42
1.1
1.1
—
—
—
0
0
49
426
1.16
0.42
2.2
2.9
1.4
0.3
e6/l
1.14
49
419
0
15
0.00
0.41
0.0
1.1
—
—
—
0
0
0
15
0.00
0.41
0.0
2.6
—
—
—
0
0
0
16
0.00
0.41
0.0
1.1
—
—
—
0
0
0
17
0.00
0.40
0.0
1.2
—
—
—
0
0
0
18
0.00
0.40
0.0
1.1
—
—
—
0
0
453
4404
1.06
0.37
3.7
4.7
206.4
2252.1
e6/l
—
8
78
59
659
0.89
0.36
1.6
1.8
2.0
1.7
%
0.68
43
543
538
5499
0.94
0.36
36.8
18.6
34.8
39.4
%
22.04
370
3476
5
79
0.63
0.35
1.6
2.5
—
—
—
0
0
43
378
1.14
0.33
3.9
4.1
47.8
47.6
%
0.02
43
373
6
47
1.28
0.32
1.0
1.1
—
—
—
0
0
11
83
1.33
0.32
1.0
2.0
—
—
—
0
0
7
53
1.32
0.31
1.0
1.3
—
—
—
0
0
7
53
1.32
0.31
1.0
1.3
—
—
—
0
0
15
185
0.81
0.30
2.8
2.3
121.5
129.5
g/l
—
10
139
12
94
1.28
0.28
1.4
1.6
—
—
—
0
0
12
94
1.28
0.28
1.4
1.6
—
—
—
0
0
12
95
1.27
0.26
1.4
1.6
—
—
—
0
0
19
224
0.84
0.25
1.6
2.5
152.6
117.4
ug/min
0.20
11
132
9
74
1.22
0.25
1.1
1.9
—
—
—
0
0
9
74
1.22
0.25
1.1
1.9
—
—
—
0
0
9
74
1.22
0.25
1.1
1.9
—
—
—
0
0
6
82
0.73
0.24
1.2
1.5
—
—
—
0
0
88
826
1.07
0.23
6.4
3.9
—
—
—
0
0
10
79
1.27
0.22
1.0
2.1
—
—
—
0
0
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
0
10
0.00
0.21
0.0
1.3
—
—
—
0
0
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
0
12
0.00
0.21
0.0
1.4
—
—
—
0
0
5
43
1.16
0.21
1.0
1.9
—
—
—
0
0
0
13
0.00
0.21
0.0
1.0
—
—
—
0
0
0
14
0.00
0.20
0.0
2.7
—
—
—
0
0
7
59
1.19
0.18
1.4
1.4
—
—
—
0
0
21
237
0.88
0.18
3.3
2.9
27.6
24.9
mmol/l
1.59
16
203
11
91
1.21
0.17
1.5
1.7
—
—
—
0
0
5
67
0.74
0.17
1.0
1.2
50.0
55.7
u/l
—
5
47
20
178
1.13
0.15
1.1
1.2
—
—
—
0
0
11
93
1.19
0.14
1.5
1.7
—
—
—
0
0
20
179
1.12
0.14
1.2
1.2
—
—
—
0
0
12
136
0.88
0.11
2.2
2.1
1.6
1.7
mmol/l
0.05
12
131
5
45
1.11
0.10
1.6
1.6
11.8
13.4
u/l
—
5
22
293
2965
0.98
0.08
3.7
4.1
38.2
59.4
ng/l
0.76
245
2332
9
87
1.03
0.07
1.9
3.1
—
—
—
0
0
297
2996
0.99
0.05
2.1
2.1
83.6
92.5
pmol/l
2.77
182
1615
18
171
1.05
0.03
1.2
1.6
—
—
—
0
0
15
158
0.95
0.02
1.4
1.5
—
—
—
0
0
10
93
1.08
0.02
1.5
1.6
—
—
—
0
0
26
253
1.03
0.01
1.1
1.1
91.7
173.1
iu/ml
—
10
88
181
1814
1.00
0.00
1.6
1.6
19.1
20.0
nmol/l
0.44
169
1512
18
181
0.99
0.00
2.8
2.8
14.1
15.9
%
—
8
99
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
5
53
0.94
0.00
1.0
1.5
—
—
—
0
0
5
53
0.94
0.00
1.0
1.5
—
—
—
0
0
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
7
70
1.00
0.00
1.1
1.1
—
—
—
0
0
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
0.00
0.0
7.0
—
—
—
0
0
0
7
0.00
0.00
0.0
1.0
—
24.7
—
0
7
0
7
0.00
0.00
0.0
1.0
—
1.6
—
0
7
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
0.00
0.0
3.4
—
—
—
0
0
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
0
5
0.00
0.00
0.0
3.0
—
—
—
0
0
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
0.00
0.0
4.5
—
—
—
0
0
0
5
0.00
0.00
0.0
1.6
—
1027.4
—
0
5
0
6
0.00
0.00
0.0
1.8
—
—
—
0
0
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
0
5
0.00
0.00
0.0
1.6
—
2.4
—
0
5
0
5
0.00
0.00
0.0
4.4
—
—
—
0
0
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
0.00
0.0
1.0
—
18.1
—
0
6
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
23
230
1.00
0.00
1.2
1.3
—
—
—
0
0
15
150
1.00
0.00
1.2
1.2
0.9
0.8
nmol/l
0.06
15
123
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
0
5
0.00
0.00
0.0
1.2
—
80.4
—
0
5
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.6
—
25.0
—
0
8
0
8
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.3
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.5
—
99.9
—
0
8
0
8
0.00
-0.00
0.0
1.3
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: C3_OESOPHAGUS – Malignant neoplasm of oesophagus
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).